Article
Epidermal growth factor receptor mutation in lung cancer are linked to bronchioloalveolar differentiation.
The American journal of surgical pathology - 1 Oct 2006
Blons Hélène, Côté Jean-François, Le Corre Delphine, Riquet Marc, Fabre-Guilevin Elisabeth, Laurent-Puig Pierre, Danel Claire
Abstract excerpt
In lung cancer, an association was made between drastic clinical response to epidermal growth factor receptor (EGFR) inhibitors and the presence of somatic mutations within the tyrosine kinase domain of the EGFR. In some cases, patients with partial response or disease stabilization do not always have EGFR-mutated tumors. To go further in the characterization of the EGF pathway, we screened EGFR, ERBB2, ERBB3,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
